Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026

Go back to Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026
VERASTEM SHS (NASDAQ: VSTM) Delayed: 8.20 +0.22 (2.76%)
Previous Close $7.98    52 Week High $2.43 
Open $7.91    52 Week Low $1.05 
Day High $8.21    P/E N/A 
Day Low $7.72    EPS $-1.79 
Volume 2,301,510